Brodin, Petter https://orcid.org/0000-0002-8103-0046
Article History
First Online: 13 January 2026
Competing interests
: P.B. is a co-founder of Cytodelics AB and a scientific advisor to Pixelgen Technologies AB (Stockholm, Sweden), Sention Health AB (Stockholm, Sweden), Helaina Inc. (New York, USA), Scailyte AG (Basel, Switzerland) and Oxford Immune Algorithmics (Reading, UK). P.B. has received speaking fees from Pfizer, Nestlé, CSL Behring, Astra Zeneca and SOBI and research grants from Pfizer, Nestlé, Astra Zeneca, Kancera AB, Infinant Health Inc. and Johnson & Johnsson.